SAN FRANCISCO, March 31, 2020 /PRNewswire/ -- The global deep
brain stimulation devices market size is anticipated to reach
USD 2.16 billion by 2027,
expanding at a CAGR of 9.6% over the forecast period,
according to a new report by Grand View Research, Inc. Increasing
prevalence of neurological diseases, preference for targeted
therapy, and technological advancements are driving the deep brain
stimulation (DBS) devices market growth.
Key suggestions from the report:
- The dual channel product segment dominated the market in
2019 owing to new product launches by key players in the
market
- Based on application, the Parkinson's disease segment
dominated the market in 2019 owing to increasing prevalence of the
disease worldwide and increasing number of FDA approvals for Deep
Brain Stimulation therapies
- The hospital end-use segment held the largest share in the
market owing to increasing prevalence of neurological disorders and
favorable reimbursement policies
- North America dominated the
DBS devices market with the highest revenue share in 2019 owing to
rising prevalence of movement and psychiatric disorders, government
initiatives, and increasing investment in R&D by the key
players
- Some of the key players operating in the deep brain
stimulation devices market are Medtronic, Abbott, Boston Scientific
Corporation, and Aleva Neurotherapeutics SA.
Read 130 page research report with ToC on "Deep Brain
Stimulation Devices Market Size, Share & Trends Analysis
Report, By Product, By Application (Parkinson's Disease, Essential
Tremor), By End Use, By Region, And Segment Forecasts, 2020 -
2027''
at: https://www.grandviewresearch.com/industry-analysis/deep-brain-stimulators-dbs-market
According to the World Health Organization (WHO), around 50
million people are living with epilepsy globally. According to the
Centers for Disease Control and Prevention (CDC), around 1.2%
population of U.S. was suffering from epilepsy in 2015, which was
around 3.4 million people including 470,000 children. In addition,
according to the Shake It Up Australia Foundation, every 40
minutes, one Australian is diagnosed with Parkinson's disease.
Increasing number of these neurological disorders is anticipated to
further drive the market growth.
Technological advancements such as enhanced microelectrode
designs, multi target stimulation, integrated implantable pulse
generators, robot-assisted implantation, and individualized
directed programming are expected to drive the market growth. Due
to these advancements, deep brain stimulators have demonstrated
greater efficacy and symptomatic relief in patients with movement
disorders than conventional methods along with lesser adverse
effects. According to a study by the U.S. National Library of
Medicine, improved electrode design has increased the efficiency of
deep brain stimulators by reducing the frequency of surgical
replacements and has led to reduced adverse effects.
Grand View Research has segmented the global deep brain
stimulation devices market based on product, application, end use
and region:
- Deep Brain Stimulation Devices Product Outlook (Revenue, USD
Million, 2016 - 2027)
-
- Single Channel
- Dual Channel
- Deep Brain Stimulation Devices Application Outlook (Revenue,
USD Million, 2016 - 2027)
-
- Pain Management
- Epilepsy
- Essential Tremor
- Obsessive-compulsive Disorder (OCD)
- Depression
- Dystonia
- Parkinson's Disease
- Others
- Deep Brain Stimulation Devices End-use Outlook (Revenue, USD
Million, 2016 - 2027)
-
- Hospitals
- Neurology Clinics
- Ambulatory Surgical Centers
- Research Centers
- Deep Brain Stimulation Devices Regional Outlook (Revenue,
USD Million, 2016 - 2027)
-
- North America
-
- Europe
-
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Netherlands
- Switzerland
- Sweden
- Ireland
- Poland
- Asia Pacific
-
- Japan
- China
- India
- Indonesia
- Australia
- South Korea
- Thailand
- Philippines
- Malaysia
- Singapore
- Latin America
-
- Mexico
- Brazil
- Argentina
- Colombia
- Chile
- Venezuela
- Middle East & Africa
-
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Iran
Find more research reports on Medical Devices
Industry, by Grand View Research:
- Brain Mapping Instruments Market – The global brain
mapping instruments market size was valued at USD 1.49 billion in 2018 and is anticipated to
grow at a CAGR 5.8%.
- Brain Implants Market – The global brain implants market
size was valued at USD 3.01 billion
in 2016. Rising incidence of neurological disorders such as
Parkinson's, Alzheimer's, epilepsy, depression, and essential
tremors.
- Mechanical Ventilators Market – The global
mechanical ventilators market size was valued at USD 4.30 billion in 2018 and is expected to
record a CAGR of 6.6% during the forecast period.
Gain access to Grand View Compass, our BI enabled
intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting
company, provides syndicated as well as customized research reports
and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425
analysts and consultants, adding more than 1200 market research
reports to its vast database each year. These reports offer
in-depth analysis on 46 industries across 25 major countries
worldwide. With the help of an interactive market intelligence
platform, Grand View Research helps Fortune 500 companies and
renowned academic institutes understand the global and regional
business environment and gauge the opportunities that lie
ahead.
Contact:
Sherry
James
Corporate Sales Specialist, US
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter
Logo:
https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg